Market revenue in 2024 | USD 584.9 million |
Market revenue in 2030 | USD 716.2 million |
Growth rate | 3.4% (CAGR from 2025 to 2030) |
Largest segment | Reagents product |
Fastest growing segment | Others Product |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments Product, Reagents Product, Others Product |
Key market players worldwide | Abbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease molecular diagnostics market will help companies and investors design strategic landscapes.
Reagents product was the largest segment with a revenue share of 67.64% in 2024. Horizon Databook has segmented the UK infectious disease molecular diagnostics market based on instruments product, reagents product, others product covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing incidence of antibiotic-resistant infections is also expected to drive the market. For instance, according to an English Surveillance Program for Antimicrobial Utilization and Resistance report, about 61,000 cases of antibiotic-resistant infections were reported in England in 2018, a 9% rise from 2017.
As per Age UK, in 2019, over 40% of the geriatric population suffered from long-standing illnesses, such as diabetes and chronic respiratory diseases. This population is highly susceptible to Intraabdominal Infections (IAIs), pneumonia, and UTIs. These infections are widespread in community settings, which is expected to increase adoption of molecular diagnostics.
In addition, increasing number of initiatives by organizations & the government to support manufacturers and researchers in the molecular diagnostic industry during the pandemic, is expected to boost market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the UK infectious disease molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into UK infectious disease molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account